These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9093709)

  • 41. Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: is it cost-effective?
    Norum J; Holtmon M
    Acta Oncol; 2005; 44(7):735-41. PubMed ID: 16227165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Is there a reliable adjuvant (intraoperative) chemotherapy of colorectal cancer?].
    Hossfeld DK
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():175-8. PubMed ID: 1983550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adjuvant chemotherapy after curative surgery for non-metastatic colorectal carcinomas (2-year results of 52 cases)].
    Boussen H; Kallel N; Khomsi F; Jerbi G; Dhouib R; Ben Safta Z; Ben Abdesselem M; el May M; Gammoudi A; Benna F; Hamza H; Dziri C; Najah N; Zaouche A; Rahal K; Ben Ayed F
    Tunis Med; 1999 Feb; 77(2):61-7. PubMed ID: 10333701
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer.
    Levy-Piedbois C; Durand-Zaleski I; Juhel H; Schmitt C; Bellanger A; Piedbois P
    Ann Oncol; 2000 Feb; 11(2):157-61. PubMed ID: 10761749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group.
    Kerr DJ; Gray R; McConkey C; Barnwell J
    Ann Oncol; 2000 Aug; 11(8):947-55. PubMed ID: 11038030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients' preferences and health economics.
    Norum J; Balteskard L; Edna TH; Laino R; Wählby L; Rønning G
    J Chemother; 2002 Jun; 14(3):301-8. PubMed ID: 12120887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant postoperative therapy of gastrointestinal malignancies.
    Ilson DH; Kelsen DP
    Oncology (Williston Park); 1994 Jul; 8(7):75-83; discussion 83, 88-90, 95. PubMed ID: 7917843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
    Cascinu S; Catalano V; Piga A; Mattioli R; Marcellini M; Pancotti A; Bascioni R; Torresi U; Silva RR; Pieroni V; Giorgi F; Catalano G; Cellerino R
    Cancer Invest; 2003; 21(5):701-7. PubMed ID: 14628428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective evaluation of toxicity in three different schedules of adjuvant chemotherapy for patients with resected colorectal cancer. TTD Spanish Cooperative Group.
    Sastre J; Navarro M; Aranda E; Fonseca E; Checa T; Alonso MC; Gallen M; Camps C; Antón A; Díaz-Rubio E
    Oncol Rep; 1999; 6(6):1421-4. PubMed ID: 10523723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
    Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
    Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
    Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
    Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant chemotherapy with 5-fluorouracil, vincristine and CCNU for patients with Dukes' C colorectal cancer. The Swedish Gastrointestinal Tumour Adjuvant Therapy Group.
    Hafström L; Domellöf L; Rudenstam CM; Norryd C; Bergman L; Nilsson T; Hansson K; Wählby L; Asklöf G; Kugelberg C
    Br J Surg; 1990 Dec; 77(12):1345-8. PubMed ID: 2276014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
    Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
    Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life in Dukes' B and C colorectal carcinoma.
    Norum J; Vonen B; Revhaug A
    Oncol Rep; 1997; 4(3):645-8. PubMed ID: 21590116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.
    Elsaleh H; Joseph D; Grieu F; Zeps N; Spry N; Iacopetta B
    Lancet; 2000 May; 355(9217):1745-50. PubMed ID: 10832824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial.
    Shiroiwa T; Takeuchi T; Fukuda T; Shimozuma K; Ohashi Y
    Value Health; 2012; 15(2):255-60. PubMed ID: 22433756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
    Bandealy MT; Gonin R; Loehrer PJ; Monaco F; Einhorn LH
    Clin Cancer Res; 1998 Apr; 4(4):935-9. PubMed ID: 9563887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.